Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Jason Strotheide, DC
Dr. Jason Strotheide is s the founder & CEO of ChiroNutraceutical, creators of the ChiroThin weight-loss program (www.ChiroThin.com). As the company’s flagship product, ChiroThin has achieved remarkable success with nearly 300,000 programs sold across the United States and Canada. Dr. Strotheide is a 1993 graduate of Logan College of Chiropractic.